Search

everythinglearnresearchcommunity

for

Search:↓

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Hair loss is often linked to thyroid problems, especially in women and older people, and screening for thyroid issues is advised for those with hair loss.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Personalized treatment plans are important for people with alopecia areata.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Mindfulness-based cognitive therapy may reduce social anxiety and improve wellbeing in people with alopecia areata.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Scalp alopecia areata mostly affects young adult males, often starts suddenly, and usually presents as single, patchy lesions.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

Tofacitinib effectively promotes hair regrowth in alopecia areata with minimal side effects.

An integrated approach can help treat childhood alopecia areata.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.